Xsira Pharmaceuticals (Transfluor technology) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Xsira Pharmaceuticals (Transfluor technology) General Information

Description

Portfolio of Transfluor technology assets. The technology comprises of proprietary assays that operate on imaging platforms such as Molecular Devices' Discovery-1 and ImageXpress systems,offers a robust way to visualize key cellular events and to detect receptor activation.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Corporate Office
  • Morrisville, NC
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xsira Pharmaceuticals (Transfluor technology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Xsira Pharmaceuticals (Transfluor technology)‘s full profile, request access.

Request a free trial

Xsira Pharmaceuticals (Transfluor technology) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Xsira Pharmaceuticals (Transfluor technology)‘s full profile, request access.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »